Moderna's COVID-19 vaccine brought in nearly $7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase agreements for another $19 billion in sales this year.
Follow Israel Hayom on Facebook, Twitter, and Instagram
The vaccine maker's COVID-19 shots, which are now available in more than 70 countries, totaled $17.7 billion in sales last year, their first full year on the market.
Moderna's COVID-19 vaccine is the only product the drugmaker has on the market.
